Pegasys Revenue and Competitors
Estimated Revenue & Valuation
- Pegasys's estimated annual revenue is currently $15.9M per year.
- Pegasys's estimated revenue per employee is $145,000
Employee Data
- Pegasys has 110 Employees.
- Pegasys grew their employee count by -5% last year.
Pegasys's People
| Name | Title | Email/Phone |
|---|---|---|
1 | junior Developer | Reveal Email/Phone |
2 | OPT RECRUITER | Reveal Email/Phone |
3 | Technical IT Recruiter | Reveal Email/Phone |
Pegasys Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $1M | 11 | -8% | N/A | N/A |
#2 | $1.4M | 16 | 0% | N/A | N/A |
#3 | $1.4M | 16 | 33% | N/A | N/A |
#4 | $0.6M | 8 | -27% | N/A | N/A |
#5 | $0.6M | 8 | 14% | N/A | N/A |
#6 | $7.2M | 55 | 10% | N/A | N/A |
#7 | $2.5M | 25 | -43% | N/A | N/A |
#8 | $6.7M | 51 | 9% | N/A | N/A |
#9 | $8M | 61 | 5% | N/A | N/A |
#10 | $0.1M | 1 | -80% | N/A | N/A |
What Is Pegasys?
Pegasys is a Global provider of Cloud Consulting Services in the field of CRM, ERP, BI, SCM & BPM company providing services to clients Worldwide working with Fortune 500 , SMB companies and Entrepreneurs Worldwide to help provide cost effective Quality Services. We are partnered with the best of the breed vendors in the above areas and has the expertise of working on more than 100 implementations on the above areas on products like Salesforce, Microsoft Dynamics, Windows Azure, Amazon AWS, Google Platform and many more. Twitter Profile: https://twitter.com/Pegasyssoft Facebook Profile: https://www.facebook.com/pegasyssoftIT Google Plus Profile: https://plus.google.com/106630047223694852009/plusones
keywords:N/A
N/A
Total Funding
110
Number of Employees
$15.9M
Revenue (est)
-5%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Pegasys News
Catalonia's regional leader accused the Spanish government on Monday of spying on its citizens after a rights group said his phone and...
... breakthrough therapies for CHB functional cure with a subcutaneously-injected PD-L1 antibody ASC22 and Pegasys® as cornerstone drugs.